Ceretype

Cambridge, United States Founded: 2020 • Age: 6 yrs
AI-based brain biomarker technology to improve drug discovery and patient care

About Ceretype

Ceretype is a company based in Cambridge (United States) founded in 2020 by Emily Stern.. Ceretype has raised $3.38 million across 2 funding rounds from investors including Cedar Street Group, Leafy Tunnel and One Mind. The company has 3 employees as of December 31, 2023. Ceretype offers products and services including Brain Insight Report and Cloud Based Platform. Ceretype operates in a competitive market with competitors including Pangea Botanica, cfdx, WM Therapeutics, La Jolla Labs and InVirtuoLabs, among others.

  • Headquarter Cambridge, United States
  • Employees 3 as on 31 Dec, 2023
  • Founders Emily Stern
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Ceretype Neuromedicine, Inc.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $3.38 M (USD)

    in 2 rounds

  • Latest Funding Round
    $2 M (USD), Seed

    Jan 04, 2024

  • Investors
  • Employee Count
    3

    as on Dec 31, 2023

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Ceretype

Ceretype offers a comprehensive portfolio of products and services, including Brain Insight Report and Cloud Based Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Provides individual fMRI-based brain maps for neurological disorders

Analyzes fMRI images for reliable brain activity measurement

People of Ceretype
Headcount 1-10
Employee Profiles 2
Employee Profiles
People
Seema Sood
Global Head - Commercial
People
Emily Stern, M.D.
CEO, Co-Founder

Unlock access to complete

Teams

Unlock access to complete

Funding Insights of Ceretype

Ceretype has successfully raised a total of $3.38M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $2 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Seed — $2.0M
  • First Round

    (09 Nov 2021)

  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Jan, 2024 Amount Seed - Ceretype Valuation Cedar Street Group
Nov, 2021 Amount Seed - Ceretype Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Ceretype

Ceretype has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Cedar Street Group, Leafy Tunnel and One Mind. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Investments are focused on alternative medicine for health solutions.
Founded Year Domain Location
Provides investment management services focused on portfolio construction and risk assessment.
Founded Year Domain Location
Mental health outcomes are improved through science and lived experience.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Ceretype

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Ceretype

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Ceretype Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Ceretype

Ceretype operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pangea Botanica, cfdx, WM Therapeutics, La Jolla Labs and InVirtuoLabs, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
AI-driven drug discovery for CNS disorders using natural compounds.
domain founded_year HQ Location
Neuroscience platform for neurogeneration research and diagnostics is provided.
domain founded_year HQ Location
Small-molecule cancer therapeutics are developed to inhibit Warburg metabolism.
domain founded_year HQ Location
RNA therapeutics for rare diseases are discovered using AI platforms.
domain founded_year HQ Location
Machine learning and physics-based simulations are provided for drug discovery.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Ceretype

Frequently Asked Questions about Ceretype

When was Ceretype founded?

Ceretype was founded in 2020 and raised its 1st funding round 1 year after it was founded.

Where is Ceretype located?

Ceretype is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.

Who is the current CEO of Ceretype?

Emily Stern is the current CEO of Ceretype. They have also founded this company.

Is Ceretype a funded company?

Ceretype is a funded company, having raised a total of $3.38M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1.38M, raised on Nov 09, 2021.

How many employees does Ceretype have?

As of Dec 31, 2023, the latest employee count at Ceretype is 3.

What does Ceretype do?

Ceretype was founded in 2020 and is based in Cambridge, United States. Operations focus on the neuropsychiatric healthcare sector, where AI-based fMRI brain imaging technology is developed to analyze brain circuitry. This approach is employed to support drug discovery processes and enhance patient care outcomes. The company is led by Co-Founder and CEO Emily Stern.

Who are the top competitors of Ceretype?

Ceretype's top competitors include Pangea Bio, cfdx and La Jolla Labs.

What products or services does Ceretype offer?

Ceretype offers Brain Insight Report and Cloud Based Platform.

Who are Ceretype's investors?

Ceretype has 3 investors. Key investors include Cedar Street Group, Leafy Tunnel, and One Mind.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available